Drug Class
proteasome inhibitor
Type
ingredient
Active Ingredient
bortezomib
📋Overview
Bortezomib is a medication classified as a proteasome inhibitor, which interferes with the breakdown of proteins within cells. It is primarily associated with the management of certain blood cancers, such as multiple myeloma and mantle cell lymphoma. By disrupting cellular processes, bortezomib can affect the growth and survival of cancerous cells. Its use is typically considered in specialized oncology settings.
📚References
Information from MedlinePlus.gov (NIH).
Found an Error?
Help us keep this information accurate. If you notice any incorrect details, please submit a correction request.
Find Discounts for Bortezomib
Hospitals.net Disclosure
Hospitals.net is an independent healthcare information platform and does not provide, administer, or guarantee prescription discounts, pricing, coupons, or pharmacy participation. All discount pricing and availability shown above are provided by RxGo and its partners and are subject to change without notice.
Hospitals.net may receive a commission or referral fee if you choose to use this prescription discount service. This does not affect the price you pay at the pharmacy. Hospitals.net is not responsible for pricing accuracy, pharmacy participation, or the fulfillment of any discount offers.